CD19 and acute lymphoblastic leukemia: Surface expression of CD19 and CD34 was not significantly different between EP300-ZNF384 (n = 7) and other pre-B-ALL groups (p = 0.7882 and p = 0.1916, respectively) (Fig. 1b).